There is no single cure for complex regional pain syndrome (CRPS), but many people do recover, especially with early treatment. The outcomes vary widely: some studies report that over 60% of patients recover well within the first year, while others find that as few as 5% are completely symptom-free at the 12-month mark. The gap between those numbers reflects differences in how “recovery” is defined and how early treatment begins. What’s clear is that CRPS is not necessarily a life sentence, but waiting to treat it makes outcomes significantly worse.
Why the Word “Cure” Is Complicated
CRPS doesn’t behave like an infection you can knock out with antibiotics. It involves a malfunction in how your nervous system processes pain signals, often triggered by an injury, surgery, or even a minor sprain. The pain is real and measurable, but it’s disproportionate to whatever caused it, and it can spread beyond the original injury site. This makes it hard to point to a single target and eliminate it.
One older study followed patients for three years and reported that 78% were “cured.” But in more rigorous prospective studies tracking patients from the onset of symptoms, only about 5% reported zero ongoing symptoms at one year. Most people fall somewhere in between: they improve substantially but may still deal with some residual pain or stiffness. The medical community generally frames successful CRPS treatment as achieving functional recovery (using the affected limb, returning to daily activities, reducing pain to manageable levels) rather than total elimination of every symptom.
Children Recover Far More Often Than Adults
If there’s a hopeful corner of CRPS research, it’s in pediatric cases. Between 50% and 90% of children and adolescents with CRPS achieve full resolution of symptoms. One study using an intensive physical therapy program (five to six hours daily for up to two weeks) showed 88% complete resolution in children, and a similar inpatient program reported 87% resolution. Relapse rates in kids range from 29% to 37%, but those relapses typically respond to the same exercise-based approach the second time around.
Adults don’t fare as well overall. Symptoms tend to improve markedly within 6 to 13 months for many patients, but retrospective studies with longer follow-up periods consistently show lasting impairments in a significant subset. The reasons for this gap likely include the greater plasticity of a younger nervous system and the fact that children are more often treated aggressively with physical therapy from the start.
CRPS Type 1 vs. Type 2
CRPS comes in two forms. Type 1, formerly called reflex sympathetic dystrophy, develops after an illness or injury with no identifiable nerve damage. Type 2, once called causalgia, involves confirmed damage to a specific nerve. Nerve conduction tests can detect the injury in Type 2 but will come back normal in Type 1. The distinction matters because Type 2 sometimes responds to treatments that target the specific injured nerve, while Type 1 requires a broader approach aimed at the nervous system’s overreaction.
Early Treatment Changes Everything
The single biggest factor in how well someone does with CRPS is how quickly treatment starts. The condition tends to become more entrenched over time as the nervous system reinforces abnormal pain pathways. Studies consistently show that patients treated within the first few months have the best chance of substantial recovery, while those whose CRPS has been present for years face a harder road. There’s no precise cutoff, but clinicians generally treat the first year as a critical window.
Getting diagnosed quickly is its own challenge. CRPS is identified using what are called the Budapest Criteria: persistent pain that’s disproportionate to whatever triggered it, plus a combination of symptoms and physical signs across four categories. These include sensory changes (heightened pain sensitivity), blood flow differences (skin color or temperature changes), swelling, and motor problems (weakness, tremor, or changes in hair and nail growth). A diagnosis requires symptoms in at least three of those four categories and visible signs in at least two.
Physical Therapy and Brain Retraining
Physical therapy is the backbone of CRPS treatment at every stage. But it’s not the kind of rehab where you simply push through pain. Standard aggressive exercise can actually make CRPS worse. The goal is to gradually recondition the brain’s relationship with the affected limb.
One of the most studied approaches is graded motor imagery, a three-phase program that works on the brain before it works on the body. In the first phase, you look at pictures of left and right limbs and identify which is which. This sounds trivially simple, but people with CRPS are measurably slower and less accurate at recognizing images of their affected side, reflecting changes in how the brain maps that part of the body. The second phase involves imagining movements of the painful limb without actually moving it. Visualizing movement activates many of the same brain areas as real movement, gently reintroducing motor signals without triggering a pain flare. The third phase is mirror therapy: you place a mirror between your limbs so the reflection of your healthy side creates the visual illusion that your affected limb is moving normally and pain-free. Each phase builds on the last, progressively increasing the sensory and motor feedback reaching the brain.
Nerve Blocks for Pain Relief
Sympathetic nerve blocks, particularly stellate ganglion blocks for upper-body CRPS, can produce significant pain reduction. In one large study of 161 patients, serial injections reduced pain scores by an average of 73% for spontaneous pain and 56% for pain triggered by touch or movement. Most patients (57%) responded well after just two injections spaced three weeks apart, though about 4% had minimal relief even after more than three rounds.
These blocks don’t cure CRPS on their own. Their real value is creating a window of reduced pain that allows patients to participate more fully in physical therapy. When someone is in too much pain to move their limb, rehab stalls. A successful nerve block can break that cycle.
Spinal Cord and Nerve Stimulation
For CRPS that doesn’t respond to first-line treatments, implantable devices that deliver mild electrical pulses to the spinal cord or specific nerve roots can help. Spinal cord stimulation (SCS) has been used for CRPS for decades, and the numbers tell a nuanced story. About 74% to 87% of patients respond well during the initial trial period, when a temporary device is tested before permanent implantation. Long-term, roughly 70% of implanted patients still use their device at eight years, and about 63% are still using it at twelve years. But 30% of permanent devices are eventually removed, mostly because pain relief fades over time.
A newer option called dorsal root ganglion (DRG) stimulation targets the nerve clusters just outside the spinal cord. It produces more stable pain relief through the first year compared to traditional spinal cord stimulation, and it can be directed more precisely to the painful area. Neither approach eliminates CRPS, but for people with severe, treatment-resistant cases, the reduction in pain can be substantial enough to restore meaningful function.
Ketamine Infusions
Ketamine, given intravenously in carefully controlled doses, is sometimes used for CRPS that hasn’t responded to other treatments. It works by blocking a type of receptor in the nervous system that’s thought to play a role in the “wind-up” of chronic pain signals. A typical protocol involves daily infusions lasting up to four hours, repeated over three to five days. Some patients receive treatments two to three times per week for one to two weeks instead. If the initial series helps, booster sessions may be offered every three months or so.
The treatment requires medical supervision because of side effects like sedation and dissociation. Results are mixed across studies, and the relief is temporary for most patients, lasting weeks to months rather than permanently. It’s generally reserved for severe cases where other options have been exhausted.
Bisphosphonate Therapy
One of the more promising pharmacological approaches involves a class of drugs originally developed for bone loss. These medications appear to work in CRPS by reducing the abnormal bone metabolism and local inflammation that drive symptoms in many patients. In a randomized trial of 78 patients with early CRPS Type 1, about 66% of those receiving the active treatment achieved at least a 50% reduction in pain within 30 days, compared to 30% in the placebo group. The treatment also significantly reduced allodynia (pain from light touch), hyperalgesia (amplified pain responses), and swelling, with no serious side effects reported. Results from multiple trials confirm that these drugs work best when used early in the disease course. They are widely used for CRPS in parts of Europe but are not yet approved for this specific use in the United States.
What Recovery Actually Looks Like
For most people with CRPS, recovery is not a single moment where the pain switches off. It’s a gradual process where pain becomes less intense, flare-ups become shorter and less frequent, and the affected limb becomes more usable. Some people reach a point where they’d describe themselves as fully recovered. Others reach a stable baseline where symptoms are present but manageable, no longer dominating their daily life. A smaller group continues to deal with significant, persistent symptoms despite treatment.
The strongest predictors of a good outcome are early diagnosis, aggressive but appropriate physical therapy from the start, and a multidisciplinary approach that combines movement-based rehabilitation with targeted pain management. No single treatment works for everyone, and most people who do well use a combination of approaches tailored to their specific symptoms and stage of the condition.